Wedbush maintains Neutral rating on Abivax, $118 price target
Wedbush kept a Neutral rating on Abivax and set a $118.00 price target, implying 30.2% upside versus the Sep 21 close of $90.65.
Story updates
12:50:02 PM UTC
SquawkNews
Ratings actions GMT) Abivax Price Target Cut to $118.00/Share From $140.00 by WedbushRatings actions